dc.contributor.author | Babiloni, Claudio | |
dc.contributor.author | Güntekin, Bahar | |
dc.date.accessioned | 2023-07-14T06:33:31Z | |
dc.date.available | 2023-07-14T06:33:31Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Babiloni, C. ve Güntekin, B. (2023). EEG, ERPs, and EROs in patients with cognitive deficits due to progressive neurodegenerative diseases: The dark side of the precision medicine. International Journal of Psychophysiology, 190, 56-59. https://doi.org/10.1016/j.ijpsycho.2023.06.005 | en_US |
dc.identifier.issn | 0167-8760 | |
dc.identifier.issn | 1872-7697 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijpsycho.2023.06.005 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/11196 | |
dc.description.abstract | Many millions of patients worldwide live with age-related progressive neurodegenerative diseases such as Alzheimer's, Parkinson's, Lewy body, and others belonging to severe cognitive deficits and disabilities in the activities of daily living (i.e., dementia) until death after a disease course of 10–15 years (Lemstra et al., 2017; Teipel et al., 2022). Indeed, no effective disease-blocking therapy is available to date. These diseases are caused by insufficient homeostasis of potentially neurotoxic proteins (e.g., amyloid, phospho tau, alpha-synuclein, TDP-43, light neurofibrillary chains) that progressively accumulate in the brain, affecting synaptic transmission and the generation and conduction of action potentials until neural loss (Lemstra et al., 2017; Jack Jr et al., 2018; Scott et al., 2022; Teipel et al., 2022). | en_US |
dc.description.sponsorship | Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment ; Global Brain Consortium ; ISTAART ; Alzheimer's Association | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier B.V. | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Precision Medicine | en_US |
dc.subject | Neurodegenerative Diseases | en_US |
dc.subject | Cognitive Deficits | en_US |
dc.subject | EROs | en_US |
dc.subject | EEG | en_US |
dc.subject | ERPs | en_US |
dc.title | EEG, ERPs, and EROs in patients with cognitive deficits due to progressive neurodegenerative diseases: The dark side of the precision medicine | en_US |
dc.type | editorial | en_US |
dc.relation.ispartof | International Journal of Psychophysiology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsü | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Biyofizik Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-0860-0524 | en_US |
dc.identifier.volume | 190 | en_US |
dc.identifier.startpage | 56 | en_US |
dc.identifier.endpage | 59 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1016/j.ijpsycho.2023.06.005 | en_US |
dc.institutionauthor | Güntekin, Bahar | |
dc.identifier.wosquality | Q2 | en_US |
dc.identifier.wos | 001030358100001 | en_US |
dc.identifier.scopus | 2-s2.0-85163220957 | en_US |
dc.identifier.pmid | 37302661 | en_US |
dc.identifier.scopusquality | Q2 | en_US |